These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21386026)

  • 1. Evaluation of contraindicated drug-drug interaction alerts in a hospital setting.
    Hatton RC; Rosenberg AF; Morris CT; McKelvey RP; Lewis JR
    Ann Pharmacother; 2011 Mar; 45(3):297-308. PubMed ID: 21386026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to automated drug alerts over time: effects on clinicians' knowledge and perceptions.
    Glassman PA; Belperio P; Simon B; Lanto A; Lee M
    Med Care; 2006 Mar; 44(3):250-6. PubMed ID: 16501396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trial of automated decision support alerts for contraindicated medications using computerized physician order entry.
    Galanter WL; Didomenico RJ; Polikaitis A
    J Am Med Inform Assoc; 2005; 12(3):269-74. PubMed ID: 15684124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overrides of medication alerts in ambulatory care.
    Isaac T; Weissman JS; Davis RB; Massagli M; Cyrulik A; Sands DZ; Weingart SN
    Arch Intern Med; 2009 Feb; 169(3):305-11. PubMed ID: 19204222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for physician non-adherence to electronic drug alerts.
    Taylor LK; Tamblyn R
    Stud Health Technol Inform; 2004; 107(Pt 2):1101-5. PubMed ID: 15360983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' decisions to override computerized drug alerts in primary care.
    Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
    Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and redesign of a knowledge database for a drug-drug interactions alert system.
    Luna D; Otero V; Canosa D; Montenegro S; Otero P; de Quirós FG
    Stud Health Technol Inform; 2007; 129(Pt 2):885-9. PubMed ID: 17911843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System).
    Guzek M; Zorina OI; Semmler A; Gonzenbach RR; Huber M; Kullak-Ublick GA; Weller M; Russmann S
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):930-8. PubMed ID: 21774031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding handling of drug safety alerts: a simulation study.
    van der Sijs H; van Gelder T; Vulto A; Berg M; Aarts J
    Int J Med Inform; 2010 May; 79(5):361-9. PubMed ID: 20171929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of alert specifications on clinicians' adherence.
    Langemeijer MM; Peute LW; Jaspers MW
    Stud Health Technol Inform; 2011; 169():930-4. PubMed ID: 21893882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribers' interactions with medication alerts at the point of prescribing: A multi-method, in situ investigation of the human-computer interaction.
    Russ AL; Zillich AJ; McManus MS; Doebbeling BN; Saleem JJ
    Int J Med Inform; 2012 Apr; 81(4):232-43. PubMed ID: 22296761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What, if all alerts were specific - estimating the potential impact on drug interaction alert burden.
    Seidling HM; Klein U; Schaier M; Czock D; Theile D; Pruszydlo MG; Kaltschmidt J; Mikus G; Haefeli WE
    Int J Med Inform; 2014 Apr; 83(4):285-91. PubMed ID: 24484781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment: evaluation of contraindicated drug-drug interaction alerts in a hospital setting.
    Horn JR; Hansten PD
    Ann Pharmacother; 2011 Jun; 45(6):826; author reply 826-7. PubMed ID: 21672901
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts.
    Glassman PA; Simon B; Belperio P; Lanto A
    Med Care; 2002 Dec; 40(12):1161-71. PubMed ID: 12458299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical decision support for monitoring drug-drug-interactions and potassium-increasing drug combinations: need for specific alerts.
    Eschmann E; Beeler PE; Kaplan V; Schneemann M; Zünd G; Blaser J
    Stud Health Technol Inform; 2012; 180():1200-2. PubMed ID: 22874400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of drug interaction software to identify alerts for transplant medications.
    Smith WD; Hatton RC; Fann AL; Baz MA; Kaplan B
    Ann Pharmacother; 2005 Jan; 39(1):45-50. PubMed ID: 15598964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings.
    Smithburger PL; Kane-Gill SL; Benedict NJ; Falcione BA; Seybert AL
    Ann Pharmacother; 2010 Nov; 44(11):1718-24. PubMed ID: 20959499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.